Frost & Sullivan Honors Codonics for Enhancing Patient Safety and Accuracy of Medication Management with the Safe Label System (SLS)
– SLS’s elegant design and integration of hardware and software elements provide a best practice approach to safe medication management with unprecedented benefits to clinicians, administrators, and pharmacists
MOUNTAIN VIEW, Calif., Nov. 20, 2014 /PRNewswire/ — Based on its recent analysis of the medication management solutions market, Frost & Sullivan recognizes Codonics with the 2014 North America Frost & Sullivan Award for Customer Value Leadership. Codonics’ Safe Label System (SLS) is an advanced, point-of-care deployable medication management device that consolidates all the best practices of pharmacies and hospitals. SLS’s easy-to-use design, functionality and workflow provide healthcare professionals with a “practice natural” means to reduce medication errors and, ultimately, improve safety and quality while enhancing focus on the patient.
Click here for the full multimedia experience of this release.
SLS enhances identification, mixing, single-dose preparation, and “smart” batch labeling to ensure efficiency with the same effectiveness, safety, and consistency as established procedures. Compliant, “smart” color labels assure that each medication is complete with 1D and 2D barcodes for barcode-enabled, point-of-care technology (BPOC) or barcode medication administration (BCMA) pre-use and delivery processing.
“In the clinical use of SLS, end users report 20-30 percent improvement in efficiency, 95 percent reduction in errors, increases in compliance, and cost avoidance by eliminating pre-filled and prepped but not used medications,” said Frost & Sullivan Research Analyst Swathi Allada.
SLS can be easily integrated with the existing healthcare workflow, including operating rooms, intensive care units (ICUs), post-anesthesia care unit (PACU), patient floors, and pharmacy. This unique system comprises two main elements:
- The SLS Administration Tool (AT), a management software that allows pharmacists and medical staff to create and control a drug formulary embodying site-specific rules for use without their physical presence at the point-of-preparation, and
- The SLS 500i Point of Care Station (PCS), which aids clinicians by providing multiple medication safety checks while increasing productivity and assuring compliance to professional organization guidance and Joint Commission standards.
Codonics employs innovative means of producing appealing, easy-to-use, precision medical devices at or below the target production cost, which has been one of the prominent aspects of the Codonics best-practice approach to medical device design. It has not only recognized the greatest needs of the medication management market, but also targeted several key customer channels to truly capitalize on the significant market opportunity.
With the development of the SLS PCS and associated AT, Codonics entered the realm of patient safety-oriented systems and expanded into the areas of anesthesia, operating room, ICU, patient floors, and pharmacy. Even in countries where specific standards or governmental oversight does not yet exist, Codonics SLS PCS is quickly becoming a standard of care worldwide, offering the best practice approach to improved medication safety.
In a truly first-of-a-kind approach, the company provides innovative design and integration that improves medication preparation, consistency, and safety by consolidating preparation confirmations. Safe Label System features include approved standard and non-standard concentrations, dilutions, and total dose/total volume configurations carried through to a compliant, “smart” medication label. These outstanding features make SLS a first-of-its-class medical device (Class 2), as reviewed and approved by the Food and Drug Administration.
“Codonics’ openness to OEM needs, discussions with international channels, and focus on gathering inputs from healthcare professionals are strategic to the development of its unique and highly satisfying products,” noted Allada. “Innovation at Codonics is iterative; the company has a feedback mechanism in place for its end users, at the beginning and also at every step of product development, to address customer needs that remained unmet by other competing products.”
Codonics is a highly intranet-centric company, where specialized “localized” order entry and accounting management systems have been developed for operations in the U.S., China, Portugal, and Japan. Sales and technical support management create and manage prospect pipelines and end-user feedback through online systems to ensure the timely processing of customer queries.
Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. The award recognizes the company’s exceptional focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and, ultimately, customer base expansion.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About Codonics
Codonics is a global business, providing healthcare with some of the most advanced medical imaging and patient safety products in the world from our headquarters in Cleveland, Ohio. Since 1982, Codonics has experienced exciting growth and award-winning achievements. Today, we are represented in 110 countries with more than 30,000 product installations in renowned, cutting-edge medical facilities throughout the world. Codonics has always looked for what has yet to come, believing that consistent dedication to advancing healthcare could transcend other ordinary solutions and conventional boundaries. Our commitment to provide innovative products and market-leading solutions is changing the face of healthcare. We are passionate about engineering products that improve medication safety so significantly they are recognized as a standard of care throughout the world. Codonics has been highly recognized for product innovation and exporting excellence with these prestigious honors: MDEA, Frost & Sullivan, Healthcare Heroes, NorTech, Stevie’s International Business, IBN Global Business Leadership, Commercial News USA, the Governor’s E-Award, and by the White House with the President’s E-Award.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on “the next big thing”
Register: Gain access to visionary innovation
Contact:
Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com
